Vitamin Shoppe, Inc. (VSI) Reaches $7.05 After 5.00% Up Move; Farr Miller & Washington Has Trimmed Johnson & Johnson (JNJ) Position

June 10, 2018 - By Darrin Black

Vitamin Shoppe, Inc. (NYSE:VSI) Logo

The stock of Vitamin Shoppe, Inc. (NYSE:VSI) is a huge mover today! The stock increased 12.80% or $0.8 during the last trading session, reaching $7.05. About 1.50M shares traded or 215.78% up from the average. Vitamin Shoppe, Inc. (NYSE:VSI) has declined 54.35% since June 10, 2017 and is downtrending. It has underperformed by 66.92% the S&P500. Some Historical VSI News: ; 22/05/2018 – Vitamin Packs Receives Significant Investment from L Catterton’s Growth Fund; 09/05/2018 – VITAMIN SHOPPE INC – ANNOUNCES SALE OF NUTRI-FORCE; 07/03/2018 Norges Bank Exits Position in Vitamin Shoppe; 23/04/2018 – VITAMIN SHOPPE INC – ALSO ENTERED INTO COOPERATION AGREEMENTS WITH VINTAGE CAPITAL MANAGEMENT LLC AND CERTAIN OF ITS AFFILIATES; 23/04/2018 – VITAMIN SHOPPE – EACH OF NEWLY APPOINTED DIRECTORS WILL STAND FOR ELECTION AT CO’S 2018 ANNUAL MEETING; 19/03/2018 – Vintage Capital Management Reports 14.8% Stake in Vitamin Shoppe; 09/05/2018 – VITAMIN SHOPPE 1Q ADJ EPS 10C, EST. 8.0C; 08/05/2018 – Tamarack Advisers Buys New 4.6% Position in Vitamin Shoppe; 17/05/2018 – Vitamin Shoppe 30.4% Owned by Hedge Funds; 09/05/2018 – Vitamin Shoppe Completes Sale of Nutri-Force for Net Proceeds of About $15MThe move comes after 9 months positive chart setup for the $170.83 million company. It was reported on Jun, 10 by Barchart.com. We have $7.40 PT which if reached, will make NYSE:VSI worth $8.54M more.




Farr Miller & Washington Llc decreased Johnson & Johnson (JNJ) stake by 1.95% reported in 2018Q1 SEC filing. Farr Miller & Washington Llc sold 6,155 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Farr Miller & Washington Llc holds 309,544 shares with $39.67M value, down from 315,699 last quarter. Johnson & Johnson now has $332.75 billion valuation. The stock increased 0.59% or $0.73 during the last trading session, reaching $124.06. About 6.21 million shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 10, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: ; 17/04/2018 – Johnson & Johnson 1Q Adj EPS $2.06; 01/05/2018 – J&J SAYS UV-BLOCKER NORBLOC+ BEHAVES AS ANTIOXIDANT; 21/05/2018 – JANSSEN PHARMACEUTICAL – VIIV HEALTHCARE WILL MARKET DOLUTEGRAVIR/RILPIVIRINE IN COUNTRIES IN EUROPEAN UNION & EUROPEAN ECONOMIC AREA; 17/04/2018 – Dominic Caruso Says Johnson & Johnson Is Still Planning for Strong 2018 (Video); 08/05/2018 – GENOMEDX BIOSCIENCES – UNDER DEAL, CO WILL TEST SAMPLES USING ITS GENOME-WIDE EXPRESSION ASSAY FROM MULTIPLE JANSSEN PROSTATE CANCER CLINICAL TRIALS; 02/04/2018 – J J EXPORTERS LTD JJEX.BO – APPROVAL OF RESIGNATION LETTER FROM S N JHUNJHUNWALA, EXECUTIVE CHAIRMAN; 08/05/2018 – J&J Presenting at Deutsche Bank Health Care Conference Tomorrow; 16/03/2018 – Johnson & Johnson Sees Deal Closing by End of 2018 If Offer Accepted; 10/04/2018 – U.S. FDA SAYS GRANTED CLEARANCE OF THE ACUVUE OASYS CONTACT LENSES WITH TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY TO JOHNSON & JOHNSON VISION CARE INC; 02/04/2018 – Fidelity Contrafund Adds Dr Pepper Snapple, Exits J&J

Analysts await Vitamin Shoppe, Inc. (NYSE:VSI) to report earnings on August, 8. They expect $0.01 earnings per share, down 95.65% or $0.22 from last year’s $0.23 per share. VSI’s profit will be $242,313 for 176.25 P/E if the $0.01 EPS becomes a reality. After $0.10 actual earnings per share reported by Vitamin Shoppe, Inc. for the previous quarter, Wall Street now forecasts -90.00% negative EPS growth.

Vitamin Shoppe, Inc., through its subsidiaries, operates as a multi-channel specialty retailer and contract maker of nutritional products in the United States and internationally. The company has market cap of $170.83 million. It operates through three divisions: Retail, Direct, and Manufacturing. It currently has negative earnings. The firm provides custom manufacturing and private labeling services for VMS products, as well as develops and markets own branded products.

Another recent and important Vitamin Shoppe, Inc. (NYSE:VSI) news was published by Streetinsider.com which published an article titled: “After-Hours Stock Movers 05/30: (TLYS) (KEYS) (VSI) Higher; (CRSP) (VCEL) (BOX) Lower (more…)” on May 30, 2018.

Among 11 analysts covering Vitamin Shoppe (NYSE:VSI), 1 have Buy rating, 2 Sell and 8 Hold. Therefore 9% are positive. Vitamin Shoppe had 27 analyst reports since August 6, 2015 according to SRatingsIntel. Barclays Capital maintained Vitamin Shoppe, Inc. (NYSE:VSI) rating on Thursday, November 9. Barclays Capital has “Equal-Weight” rating and $3 target. The firm has “Sell” rating by Zacks given on Saturday, August 8. Goldman Sachs downgraded the shares of VSI in report on Thursday, January 19 to “Sell” rating. Robert W. Baird downgraded the shares of VSI in report on Tuesday, November 17 to “Neutral” rating. Morgan Stanley downgraded Vitamin Shoppe, Inc. (NYSE:VSI) on Tuesday, January 17 to “Underweight” rating. Morgan Stanley downgraded the shares of VSI in report on Thursday, November 3 to “Equal-Weight” rating. The stock of Vitamin Shoppe, Inc. (NYSE:VSI) has “Hold” rating given on Friday, September 15 by Robert W. Baird. The firm earned “Neutral” rating on Thursday, October 27 by JP Morgan. Gabelli downgraded the stock to “Hold” rating in Thursday, May 11 report. On Thursday, April 21 the stock rating was initiated by Wedbush with “Outperform”.

Investors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Parsec Mgmt invested in 170,529 shares. American Bancshares has invested 1.71% in Johnson & Johnson (NYSE:JNJ). Gateway Investment Advisers Ltd Company owns 1.39M shares for 1.58% of their portfolio. 40,674 were accumulated by Kistler. Hm Payson & holds 3.19% or 604,119 shares in its portfolio. Horan has 17,293 shares. Colonial Tru Advisors invested in 126,009 shares. Tru Com Of Toledo Na Oh has 30,617 shares. Wolverine Asset Mgmt Ltd Company invested 1.66% in Johnson & Johnson (NYSE:JNJ). Moreover, Stratford Consulting Ltd Co has 0.11% invested in Johnson & Johnson (NYSE:JNJ) for 2,335 shares. Sun Life Fin holds 1,759 shares. Mount Vernon Assoc Md accumulated 0.53% or 2,680 shares. Green Square Ltd Liability Com owns 50,893 shares. Cahill Advsr Incorporated holds 0.41% in Johnson & Johnson (NYSE:JNJ) or 6,734 shares. Kingfisher Cap Limited Liability Company has invested 1.57% in Johnson & Johnson (NYSE:JNJ).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 101 analyst reports since August 7, 2015 according to SRatingsIntel. Barclays Capital downgraded Johnson & Johnson (NYSE:JNJ) on Tuesday, November 29 to “Equal-Weight” rating. The firm earned “Buy” rating on Tuesday, September 22 by UBS. The stock of Johnson & Johnson (NYSE:JNJ) has “Sell” rating given on Tuesday, January 23 by BTIG Research. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Argus Research on Wednesday, July 20. The rating was maintained by BMO Capital Markets with “Buy” on Friday, June 2. UBS maintained it with “Buy” rating and $144.0 target in Wednesday, October 19 report. Vetr downgraded the shares of JNJ in report on Monday, August 31 to “Strong-Buy” rating. The firm has “Outperform” rating given on Wednesday, January 25 by RBC Capital Markets. The stock has “Buy” rating by BMO Capital Markets on Thursday, August 31. The firm has “Equal-Weight” rating by Barclays Capital given on Wednesday, October 18.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.06 earnings per share, up 12.57% or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53B for 15.06 P/E if the $2.06 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.